| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.007 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |